Kopin Receives Initial Production Order for Advanced Surgical Information Display
January 23 2024 - 7:30AM
Business Wire
Kopin Corporation (NASDAQ: KOPN), a leading provider of
application-specific optical solutions and high performance
micro-displays for defense, enterprise, consumer and medical
products, today announced it has received an initial production
order for the CR3 wearable surgical monitor from HMDmd Inc
(HMDmd).
The CR3 is a head-mounted display (“HMD”) system that is the
culmination of a multi-year development program by Kopin and HMDmd
to produce a medical-grade wearable monitor that meets the exacting
needs of surgeons and supporting clinical personnel. The CR3
provides full-HD resolution 3-D imagery in a lightweight, ergonomic
package and is 4K video compatible. The CR3 is configured for use
with 2-D and 3-D endoscopes and operating microscopes/exoscopes and
is plug-in compatible with products produced by major surgical
systems companies.
“Kopin’s CR3 head-mounted monitor is a truly ground-breaking
wearable that is purpose-built for surgeons and builds upon Kopin’s
extensive experience with high-performance head-mounted military
pilot, soldier, and training microdisplay systems,” said Bill
Maffucci, Kopin's Senior Vice President of Business Development and
Strategy. “The CR3 incorporates advanced design features that
satisfy critical human visual system and ergonomic factors,
resulting in an HMD with outstanding 3D imagery that is comfortable
to view and wear over long-duration procedures.”
The CR3 enables surgeons to maintain a direct view of the
surgical field while also being able to easily access critical
information, such as live video feeds from surgical instruments and
diagnostic images, by simply glancing up to see needed information
on the head-worn display system, as opposed to constantly moving
their head up to see a monitor and then down to see the
patient.
John Lyon, CEO of HMDmd, said, "The specification of CR3 and
guiding principles of its development have been to provide surgeons
with high-resolution 2D and 3D video imagery and superior
ergonomics while performing surgery. The CR3 provides a
functionality leap from the current solution, which involves
looking away at a remotely positioned conventional video monitor.
In the development process Kopin's deep experience in the design
and production of mission-critical, head-mounted microdisplay
systems for the military proved critical. We anticipate that our
focus on superior ergonomics will be particularly beneficial for
surgical use-cases in microscopy, minimally invasive surgery,
digital and robotic surgery and interventional medicine. The
feedback from surgeons and surgical equipment manufacturers has
been very positive.”
About Kopin
Kopin Corporation is a leading developer and provider of
innovative display and optical technologies sold as critical
components and subassemblies for defense, industrial and consumer
products. Kopin's technology portfolio includes ultra-small
Active-Matrix Liquid Crystal displays (AMLCD), Liquid Crystal on
Silicon (LCOS) displays and Organic Light Emitting Diode (OLED)
displays, a variety of optics, and low-power ASICs. For more
information, please visit Kopin's website at www.kopin.com.
About HMDmd, Inc.
HMDmd, based in Solana Beach, CA, is entirely focused on
providing high-performance wearable display systems for surgery,
interventional medicine and other medical specialties and
applications. The Company's business model is to provide
customized, medical grade headsets to be integrated as the display
component of proprietary systems commercialized by strategic
distribution partners. For further information see www.hmdmd.com or
contact John Lyon, CEO: john.lyon@hmdmd.com.
Forward-Looking Statements
Statements in this press release may be considered
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933, as amended (the “Securities Act”), and
Section 21E of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), which are subject to the safe harbor created by
such sections. Words such as “expects,” “believes,” “can,” “will,”
“estimates,” and variations of such words and similar expressions,
and the negatives thereof, are intended to identify such
forward-looking statements. We caution readers not to place undue
reliance on any such “forward-looking statements,” which speak only
as of the date made, and advise readers that these forward-looking
statements are not guarantees of future performance and involve
certain risks, uncertainties, estimates, and assumptions by us that
are difficult to predict. These forward-looking statements may
include statements with respect to our expectation that our focus
on superior ergonomics will be particularly beneficial for surgical
use-cases in microscopy, minimally invasive surgery, digital and
robotic surgery and interventional medicine. Various factors, some
of which are beyond our control, could cause actual results to
differ materially from those expressed in, or implied by, such
forward-looking statements. All such forward-looking statements,
whether written or oral, and whether made by us or on our behalf,
are expressly qualified by these cautionary statements and any
other cautionary statements that may accompany the forward-looking
statements. In addition, we disclaim any obligation to update any
forward-looking statements to reflect events or circumstances after
the date of this press release, except as may otherwise be required
by the federal securities laws. These forward-looking statements
are only predictions, subject to risks and uncertainties, and
actual results could differ materially from those discussed.
Important factors that could affect performance and cause results
to differ materially from management’s expectations are described
in Part I, Item 1A. Risk Factors; Part II, Item 7. Management’s
Discussion and Analysis of Financial Condition and Results of
Operations; and other parts of our Annual Report on Form 10-K for
the fiscal year ended December 31, 2022, or as updated from time to
time our Securities and Exchange Commission filings.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240123123220/en/
Kopin Corporation Bill Maffucci, 508-870-5959 SVP of Business
Development and Strategy, bmaffucci@kopin.com
Richard Sneider, 508-870-5959 Treasurer and Chief
Financial Officer Richard_Sneider@kopin.com
or
MZ Contact: Brian M. Prenoveau, CFA, 561 489 5315 MZ
Group – MZ North America KOPIN@mzgroup.us
HMDmd Inc John Lyon, 760-518-1132 CEO John.lyon@hmdmd.com
Kopin (NASDAQ:KOPN)
Historical Stock Chart
From Apr 2024 to May 2024
Kopin (NASDAQ:KOPN)
Historical Stock Chart
From May 2023 to May 2024